Meta-analysis of defibrase in treatment of acute cerebral infarction

Chinese Medical Journal

Volumn 119, Issue 8, 2006, Pages 662-668

  Guo, Yi ^a   Zuo, Yan Fang ^a   Wang, Qi Zhang ^a   Tang, Bing Shan ^a   Li, Fu Kang ^a   Sun, Yi ^b  

^a JINAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cerebral infarction; Defibrase; Meta analysis; Treatment

Indexed keywords

ANCROD; BATROXOBIN; FIBRINOGEN; PLACEBO; FIBRINOLYTIC AGENT;

ACUTE DISEASE; ANTICOAGULATION; BARTHEL INDEX; BRAIN INFARCTION; CHINA; CLINICAL TRIAL; CONFIDENCE INTERVAL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FIBRINOGEN BLOOD LEVEL; HUMAN; MEDICAL RECORD; MEDLINE; META ANALYSIS; NEUROLOGIC DISEASE; OUTCOMES RESEARCH; RECURRENT DISEASE; REVIEW; SCORING SYSTEM; STROKE; SYSTEMATIC REVIEW; ADULT; AGED; ARTICLE; BLOOD; MIDDLE AGED;

ACUTE DISEASE; ADULT; AGED; BATROXOBIN; CEREBRAL INFARCTION; FIBRINOGEN; FIBRINOLYTIC AGENTS; HUMANS; MIDDLE AGED;

EID: 33646843550     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200604020-00010     Document Type: Review

References (22)

1. Huang RX, Zeng JS, Cheng LY, Ren HM, Lu CZ, Yin L, et al. Experimental study on effects of defibrase in treatment of middle cerebral artery thrombosis and cerebral infarction. Chin J Nerv Ment Dis (Chin) 2001; 27:335-337.
2. The Cooperative Group for Reassessment of Defibrase. Reassessment of defibrase in treatment of cerebral infarction. Chin J Neurol (Chin) 2000; 33:263-267.
3. Chinese Neurological Association. Diagnosis for all kinds of cerebralvascular disease. Chin J Neurol (Chin) 1996; 29:379.
4. Yang QC, Zhang XD, Guo YP, Liang CC, Qin HX, Yang XL, et al. Clinical contrast study on urokinase, defibrase and normal treatment on acute cerebral ischemic. Chin General Practice (Chin) 2005; 8:193-195.
5. Fan W, Jin LR, Wang X, Guo SY, Zhang YH, Fei GQ, et al. A contrast treating acute cerebral infarction by protease. Shanghai Med Univ (Chin) 2000; 27:413-414.
6. Mei YW, Deng XJ, Wei GR, Chen JX, Liu CQ, Xing HY, et al. Clinical analysis of 29 cases of acute cerebral infarction treated by defibrase. Snake J 2000; 12:22-24.
7. Yu NW, Yang YS, Xiao J, Dai HY, Liu J, Xu F, et al. Observation of the effect of treating acute cerebral infarction of 53 patients with defibrase by random double-blind method and surveyed for 3 years. J Brain Nervous Dis 2003; 11:241-243.
8. Xie LC, Wei LH, Guan JZ, Niu XY, Guo JH, Li XY, et al. Effects of defibrase on acute cerebral infarction. J Shanxi Med Univ (Chin) 2003; 34:530-532.
9. Yang Q, Cheng OW, Peng GG, Dong WW. Reassessment of defibrase in treatment of cerebral infarction. J Chongqing Med Univ (Chin) 2004; 29:477-479.
10. Xu MJ, Lu Y, Song SP, Yuan WH, Li LL, Li W, et al. A contrast research on treating acute cerebral infarction by protease. China New Med (Chin) 2003; 1:5-6.
11. Wang YZ, Song BS, Xu WH, Yu F, Wang GP, Zhao JM, et al. A randomized double-blind placebo-controlled study of defibrase in the treatment of cerebral infraction. Anhui Med J (Chin) 2004; 25:92-94.
12. Lu J, Yan SQ, Ji YS, Wu SJ, Kong FY. Reassessment of defibrase in treatment of cerebral infarction with double-blind, and placebo-controlled clinical trial. Shanxi Med J (Chin) 2003; 32:539-540.
13. Li SD, Guo CJ, Guo CJ, Xu J, Zhang QJ. A prospective, double-blind, randomized, placebo controlled trial research on defibrase for the treatment of acute ischemic bra in infarction. Snake J 1999; 11:23-25.
14. Li QM, Wang Q, Tan L, Fan YH, Pei HT, Zhao RL, et al. Study of a double-blinded control trial in treating acute cerebral infarction with defibrase. Snake J 2000; 12:1-4.
15. Guan XT, Long J, Dong KH, Cai B, Wang SX, Zhang N, et al. Clinical study on the defibrase in the treatment of 90 cases of acute ischemic cerebral infarction. Chin General Practice (Chin) 2001; 4:948-950.
16. Wu HX, Liu W, Qing AJ, Wang XL, Liang H, Di TY, et al. Double blind comparison of therapeutic effect of defibrase on acute cerebral infarct ion. Snake J 2001; 12:25-27.
17. Luo HY, Hu CL. Observation of the therapeutic effect of defibrase on acute cerebral infarction. China J Contemp Neurol Neurosurg (Chin) 2004; 4:57-59.
18. Sherman DG, Atkinson RP, Chippendale T, Levin KA, Ng K, Futrell N, et al. Intravenous ancrod for treatment of acute ischemic stroke: The STAT Study: A randomized controlled trial. JAMA 2000; 283:2395-2403.
19. Sherman DG. Antithrombotic therapy in the acute phase: new approaches. Cerebrovasc Dis 2001; 11 Suppl 1:49-54.
20. Orgogozo JM, Verstraete M, Kay R, Hennerici M, Lenzi GL. Outcomes of ancrod in acute ischemic stroke. Independent Data and Safety Monitoring Board for ESTAT. Steering Committee for ESTAT. European Stroke Treatment with Ancrod Trial. JAMA 2000; 284(15):1926-1927.
21. The Cooperative Group for Reassessment of Defibrase. Reassessment of defibrase in treatment of cerebral infarction (II). Chin J Neurol (Chin) 2005; 38:11-16.
22. Liu M, Counsell C, Zhao XL, Wardlaw J. Fibrinogen-depleting agents for acute ischemic stroke. Stroke 2005; 36: 173-174.